The burden-of-illness study on osteoporosis in the Slovenian female population
- Biljana DzajkovskaAffiliated withMillennium Pharmaceuticals, Ltd.Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy Email author
- , Albert I. WertheimerAffiliated withCenter for Pharmaceutical Health Services Research, Temple University School of Pharmacy
- , Ales MrharAffiliated withDepartment of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
This burden-of-illness study on osteoporosis was performed with the main goal to estimate the economic implications of osteoporosis for the Slovenian healthcare system.
A variety of sources was used to quantify the utilization of resources in 2003, and the appropriate unit costs were assigned to the identified resources.
Main outcome measures
The study included all direct and indirect costs that arise from treatment of osteoporosis and consequent hip, spine and wrist fractures in total Slovene postmenopausal population in 2003.
We estimated the total burden of postmenopausal osteoporosis in Slovenia for 2003 to be over SIT 7.55 billion (approximately €31.5 million); among that, 45% or SIT 3.39 billion (€14.2 million) belong to drug expenditures for osteoporosis treatment and prevention; 29% or SIT 2.2 billion (€9.2 million) include indirect costs for osteoporosis morbidity and mortality, and 26% or SIT 1.95 billion (€8.1 million) belong to direct costs for treatment, hospitalization, and rehabilitation of osteoporotic fractures. Total costs on osteoporotic fractures were however subject to an approximation due to the expert panel-based estimate of proportion of osteoporosis-caused fractures and the limited data on resource utilization for fracture treatment.
Osteoporosis is a costly disease with a significant burden to society and needs to be viewed as an important problem with a complex long-term impact.
KeywordsBone fractures Burden-of-illness Costs Economics Health policy Osteoporosis Slovenia
- The burden-of-illness study on osteoporosis in the Slovenian female population
Pharmacy World & Science
Volume 29, Issue 4 , pp 404-411
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Bone fractures
- Health policy
- Industry Sectors
- Author Affiliations
- 1. Millennium Pharmaceuticals, Ltd., Building 3, Chiswick Park, 566 Chiswick High Road, London, W4 5YA, UK
- 2. Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, Askerceva 7, 1000, Ljubljana, Slovenia
- 3. Center for Pharmaceutical Health Services Research, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA, 19140, USA